Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder

NCT05322954 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped due to sponsor financial constraints

Conditions

Methamphetamine Use Disorder
Substance-Related Disorders
Chemically-Induced Disorders
Substance Use Disorders
Stimulant-Use Disorder

Interventions

DRUG: Psilocybin

Sponsor

University of Wisconsin, Madison

Collaborators

Revive Therapeutics, Ltd.